Celsis’
Accel system allows products to be quickly released from micro hold
reducing manufacturing cycle times and inventory requirements for Home,
Beauty and Pharmaceutical product manufacturers
LONDON. - Wednesday, February 4th 2015 [ME NewsWire]
(BUSINESS
WIRE) Celsis, the global leader in rapid microbial testing systems for
industry, today introduced the Celsis Accel system, the most robust and
easiest-to-use rapid microbial screening system for small and
medium-size manufacturing companies.
Utilizing Celsis’
proprietary reagent technology, the Celsis Accel system reduces time
necessary for quality control assessment of microbial contamination.
This shortens production cycle times by lowering quarantined inventory
levels awaiting quality control release and reduces working capital
requirements. Faster quality control results also provide an earlier
indication of contamination allowing a faster and more effective
investigation and corrective action, thereby reducing the economic
impact of the event.
Using its Financial Impact Assessment (FIA),
Celsis works with hundreds of manufacturing facilities around the world
to evaluate the cost savings of implementing a Celsis system. Utilizing
company specific information including the value of products and the
time and cost comparisons associated with the Celsis method, the FIA
projects the 5-year Net Present Value (NPV) of a company’s investment in
the Celsis system. The 5-year NPV for the average manufacturing
facility is typically in excess of $300,000.
The Celsis Accel
takes the robustness and ease-of-use of the widely adopted Celsis
Advance platform packaged into a compact system specifically designed
for small and medium-size manufacturing facilities. Easy-to-use,
easy-to-learn software makes the Celsis Accel a great fit for Home,
Beauty and Pharmaceutical product manufacturers’ busy microbiology labs.
To read more about the new Celsis Accel system online, please visit celsis.com/Accel
“Celsis
works with product manufacturers of all sizes. Small and medium-size
manufacturers have different testing requirements than large
manufacturers and were asking for an instrument designed to meet their
needs,” said Jay LeCoque, CEO. “Responding to this demand, we developed
the Accel for manufacturers whose testing requirements are smaller, but
we employed the same robustness and ease-of-use of our popular large
capacity Advance platform.”
To allow maximum flexibility with
sample size and sensitivity, Celsis adapted the familiar sample tube
platform to a precision movement carousel for easy loading and speedy
processing with the ability to run 30 assays at a time. A fourth
injector position gives the system flexibility to use new reagent
technologies as they are developed. From reagent bottle access to sample
loading, the ergonomic design puts everything easily at the fingertips
of the user.
Celsis Accel.im™ takes advantage of current Celsis
software innovations, such as a new ribbon menu system, data security
features, and the ability to export sample results. User administration
features, an event log and more allow users full compliance with the
FDA’s CFR 21 Part 11 and the EU’s Annex 11.
Proven rugged and
reliable systems, plus dedicated global support, have made Celsis the
industry standard for leading manufacturers around the world. Celsis
systems are used to rapidly and effectively screen a variety of Home,
Beauty and Pharmaceutical products — including body washes, lotions,
soaps, toothpastes, liquid detergents, cosmetics, tablets and ointments,
IV solutions and oral drug suspensions — helping companies save time
and money while releasing safe products to market.
To read more about the new Accel system online, please visit celsis.com/Accel
For
more information about Celsis products and services for the Home,
Beauty and Pharmaceutical industries, please visit celsis.com or call +1
312 476 1282.
Contacts
Media
Celsis, Inc.
Liz Garvey, +1 312 476 1218
lgarvey@celsis.com
Permalink: http://me-newswire.net/news/13553/en
No comments:
Post a Comment